NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Clinical trials for NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) explained in plain language.
Never miss a new study
Get alerted when new NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) trials appear
Sign up with your email to follow new studies for NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First patients receive experimental cancer drug targeting multiple tumor types
Disease control Recruiting nowThis is the first study in humans testing a new drug called KO-2806, both alone and combined with other cancer therapies. It aims to find safe doses and see early signs of effectiveness in 300 adults with advanced solid tumors that have specific genetic changes, including certain…
Matched conditions: NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Apr 03, 2026 21:40 UTC
-
New cancer drug combo trial seeks to control advanced tumors
Disease control Recruiting nowThis study is testing a new drug called XL092, both by itself and in combination with other immunotherapy drugs, for people with advanced solid tumors that cannot be removed by surgery. The main goals are to find safe doses and see if the treatments can shrink tumors or slow thei…
Matched conditions: NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC